AstraZeneca plots US stock listing amid industry pullback from Britain

29th September 2025 Uncategorised 0

In a bid to “harmonize its share listing structure,” AstraZeneca aims to list its shares directly on the New York Stock Exchange. While AZ will continue to trade on the London Stock Exchange and retain its U.K. headquarters, the move comes at a time when multiple drugmakers are reducing their focus on Britain.

More: AstraZeneca plots US stock listing amid industry pullback from Britain
Source: fierce